Exchange: NASDAQ·Updated 06:32 PM EDT

INCY News

News
all
press releases
Why Is Acadia (ACAD) Up 0.5% Since Last Earnings Report?
Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
More News
Incyte to Present at Upcoming Investor Conferences
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September: 21st Annual Wells Fargo Healthcare Conference on Wednesday, September 9, 2026 at 11:00 a.m. EDT Cantor Global Healthcare Conference 2026 on Thursday, September 10, 2026 at...
Business Wire
Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?
uniQure (QURE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Incyte (INCY) Up 0.8% Since Last Earnings Report: Can It Continue?
Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
SYRE expands into HS with SPY772, testing whether dual-pathway inhibition can strengthen outcomes in SKYLIGHT.
Zacks
Here's How Much You Would Have Made Owning Incyte Stock In The Last 20 Years
Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.29% on an annualized basis producing an average annual return of 17.52%. Currently, Incyte has a market capitalization of $25.75 billion.read more...
Benzinga
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Companys common stock and stock option awards to purchase an aggregate of 18,172 shares of the Companys common stock to 24 new employees. The...
Business Wire
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised
MIRM Q2 earnings miss estimates while revenues beat the same, as Livmarli and bile acid drugs fuel growth, prompting a higher 2026 sales outlook.
Zacks
REGN or INCY: Which Is the Better Value Stock Right Now?
REGN vs. INCY: Which Stock Is the Better Value Option?
Zacks
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS PR Newswire SINGAPORE, Aug. 2, 2026 Minjuvi (tafasitamab), in combination with rituximab and lenalidomide, is the first...
PR Newswire

Advertisement|Remove ads.